Nomination committee’s proposal for composition of the Board

The Nomination Committee of Meda AB proposes the election of Guido Oelkers and
Martin Svalstedt as new board members and proposes the appointment of Martin
Svalstedt as Board Chairman. The committee further proposes the re-election of
Peter Claesson, Peter von Ehrenheim, Marianne Hamilton, Tuve Johannesson, Karen
Sörensen and Lars Westerberg. Former CEO and board member Anders Lönner stepped
down from the board when he stepped down from the position of CEO, and current
Board Chairman Bert Åke Eriksson has declined re-election to the board.

Guido Oelkers is currently CEO of BSN Group, Hamburg. Oelkers has previous been
CEO of Gambro AB and has experience from several global assignments. He holds a
Ph.D. in strategic management.

Martin Svalstedt is currently CEO of Adactum AB, Stena sphere’s investment
company, and is Board Chairman of Gunnebo AB and Ballingslöv AB. Svalstedt holds
a Master of Science in Business Administration and Economics.

The nomination committee for the AGM 2014 consists of Evert Carlsson (Swedbank
Robur Funds), Lars Backsell (B&E Participation AB), Anders Oscarsson (AMF
Funds), Bert Åke Eriksson (Meda’s Chairman of the Board) and Karl-Magnus Sjölin
(Stena Sessan).

The nomination committee's other proposals concerning the chairman of the
meeting, remuneration and the method used to appoint the nomination committee
will be disclosed on the website and in the notice of the Annual General
Meeting.

The Annual General Meeting of Meda AB will be held on May 7, 2014 at 17.00 CET
at Meda AB, Pipers väg 2A, Solna, Sweden.


For further inquiries, please contact:

Paula Treutiger, Investor Relations
ph: +46 733
-666 599

paula.treutiger@meda.se

Karl-Magnus Sjölin, Chairman of the Nomination Committee
ph: +46 31-774 35 35

MEDA AB (publ) is a leading international specialty pharma company. Meda’s
products are sold in more than 120 countries worldwide and the company is
represented by its own organizations in over 55 countries. The Meda share is
listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm.
Find out more, visit www.meda.se.